PI
Indication and Usage
Aralast NP is an alpha1-Proteinase inhibitor indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe congenital deficiency of Alpha1-PI
Adverse Reactions
Headache, musculoskeletal discomfort, vessel puncture site bruise, nausea and rhinorrhea
How long has Aralast been prescribed for
Since 2002 (18years)
JCode
J0257
How many IBM's are there currently for Alpha1
41
Unlike Glassia being liquid ready, Aralast involves what before being administered
HINT(section 2.2)
Reconstitution
None reported in clinical trials
Storage Temperature
Temperatures not to exceed 25 C (77F)
Glassia received FDA approval when?
2009
Hudson
Infusion Rate
A rate not to exceed 0.2mL per kg body weight per minute, and as determined by the response and comfort of the patient.
Dosage Forms and Strengths
Lyophilized Powder in single does vials containing .5gram or 1gram of functional Alpha1-PI
ICD-10 Code for AAT
E88.01
What key item is not supplied with Glassia that our dosage and administration guide gives ordering info for
5 micron in-line filter
What state is responsible for the most elected Presidents?
(Hint: It's one of our groups territory)
Ohio(will also accept Virginia)
Contraindications
IgA deficient patients with antibodies against IgA, due to the risk of severe hypersensitivity.
_______ to reduce the risk of harmful microbial growth.
3 Hours
For administration what type of filter is used?
20 micron filter
Serious Adverse Reaction
Exacerbation of COPD
42
Dosage
60mg/kg body weight once weekly by IV
JCode for Aralast
J0256
_______ is personalized product support after you and your patient choose a treatment path
OnePath
First FDA approved liquid augmentation therapy
Glassia
What college did Brian Grawer play basketball for?
Missouri